HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goodwin, A. T. Articles by Yacoub, M. H. Search for Related Content PubMed PubMed Citation Articles by Goodwin, A. T. Articles by Yacoub, M. H.

European Journal of Cardio-Thoracic Surgery, Vol 11, 981-987, Copyright © 1997 by European Association for Cardio-thoracic Surgery

ARTICLES

Inhibition of endogenous endothelin during cardioplegia improves low coronary reflow following prolonged hypothermic arrest

AT Goodwin, M Amrani, CC Gray, AH Chester and MH Yacoub
Department of Cardiac Surgery, Heart Science Centre, Harefield Hospital, Middlesex, UK. Andrew.Goodwin@harefield.nthames.nhs.uk

OBJECTIVE: Endothelin-1 (ET) is a potent endogenous vasoconstrictor which has been shown to be increased following ischaemia and cardiopulmonary bypass. We tested the hypothesis that inhibition of ET synthesis during cardioplegic arrest using phosphoramidon (an ET converting enzyme inhibitor) or blockade of ET receptors using bosentan (a mixed ET(A)/ET(B) antagonist), might improve the postischaemic recovery of coronary flow. METHODS: Using an isolated Langendorff perfused rat heart model we compared the addition of phosphoramidon or bosentan to St Thomas' Hospital No. cardioplegia vs. control (plain cardioplegia). We measured recovery of coronary flow following 4 h of cardioplegic arrest at 4 degrees C. In a second series of experiments using an isolated working rat heart model we measured the recovery of cardiac function following 4 h of cardioplegic arrest at 4 degrees C. Results are expressed as percentages of preischaemic values (+/- S.E.M). RESULTS: In the first series of experiments, addition of phosphoramidon to cardioplegia improved the postischaemic recovery of coronary flow after 30 min of reperfusion: control 81.3% (+/- 3.5); phosphoramidon 10(-6) M 86.2% (+/- 3.1); phosphoramidon 10(-5) M 95.0% (+/- 3.0) P = 0.03 vs. control. Likewise, addition of bosentan 10(-5) M improved coronary flow following 20 min of reperfusion: control 96.7% (+/- 4.0), and bosentan 109.6% (+/- 4.7) P = 0.04. The addition of phosphoramidon or bosentan had no effect on the postischaemic recovery of mechanical function following 30 min of reperfusion. CONCLUSION: Both inhibition of ET synthesis and ET receptor blockade during prolonged hypothermic arrest improves postischaemic coronary flow, but appears to have no effect on the recovery of cardiac mechanical function.

This article has been cited by other articles:

				A. T. Goodwin, R. T. Smolenski, C. C. Gray, J. Jayakumar, M. Amrani, and M. H. Yacoub Role of endogenous endothelin on coronary reflow after cardioplegic arrest J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1167 - 1173. [Abstract] [Full Text] [PDF]

				C. Joffs, C. A. Walker, J. W. Hendrick, D. J. Fary, D. K. Almany, J. N. Davis, A. T. Goldberg, F. A. Crawford Jr, and F. G. Spinale Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 365 - 370. [Abstract] [Full Text] [PDF]

				C. A. Walker, S. C. Baicu, A. T. Goldberg, C. E. Widener, D. J. Fary, D. K. Almany, A. Ergul, F. A. Crawford Jr, and F. G. Spinale Temporal endothelin dynamics of the myocardial interstitium and systemic circulation in cardiopulmonary bypass J. Thorac. Cardiovasc. Surg., November 1, 2000; 120(5): 864 - 871. [Abstract] [Full Text] [PDF]

				A. T Goodwin, M. Amrani, A. J Marchbank, C. C Gray, J. Jayakumar, and M. H Yacoub Coronary vasoconstriction to endothelin-1 increases with age before and after ischaemia and reperfusion Cardiovasc Res, March 1, 1999; 41(3): 554 - 562. [Abstract] [Full Text] [PDF]

				G. Szabo, L. Fazekas, S. Bahrle, D. MacDonald, N. Stumpf, C. F Vahl, and S. Hagl Endothelin-A and -B antagonists protect myocardial and endothelial function after ischemia/reperfusion in a rat heart transplantation model Cardiovasc Res, September 1, 1998; 39(3): 683 - 690. [Abstract] [Full Text] [PDF]